Therapeutic Massage to Manage Withdrawal Related Anxiety
NCT00992979 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 80
Last updated 2009-10-09
Summary
In Canada, Addiction Prevention and Treatment Service's (APTS) offer programs specifically designed to help people withdrawal from psychoactive drugs. While participants of withdrawal management (Detox) programs generally reach their goals, the process is a difficult one often exacting an emotional and physical toll. Troublesome symptoms of withdrawal from psychoactive drugs may include anxiety and sleep disturbances. If untreated these symptoms can lead to discontinuation of withdrawal and /or affect the introduction of cognitive-behavioral and or motivational therapy components of Detox programs. In Detox the symptoms of withdraw are managed pharmacologically. Pharmacological tools for managing anxiety and sleep disturbances exist and while effective and safe, in many clinical settings, have limitations and liability in the addiction treatment setting. To address these concerns APTS has incorporated non-pharmacological anxiety management practices into its programs. Prominent among these is therapeutic massage (chair massage in the Swedish tradition). While therapeutic massage has been shown to reduce state and trait anxiety in a variety of clinical settings, no previous study has assessed its anxiolytic or sleep promoting efficacy in an addiction treatment setting. In keeping with ATPS's policy on evidence-based practice, evidence in support of this practice is now required.
Research Objectives: We propose to test the Hypothesis: Therapeutic Massage is an effective therapy for managing withdrawal-related anxiety and for improving sleep effectiveness in patients withdrawing from psychoactive drugs. Our specific objective is to perform a randomized controlled trial (RCT) to determine whether therapeutic massage is effective in comparison to relaxation control treatment in reducing the levels of state and trait anxiety associated with withdrawal and in promoting sleep efficiency.
Research Design: A RCT of the effects of therapeutic massage will be conducted on 80 patients (ages 18-65) attending an APTS Detox program. Patients will be assigned to 1 of 2 treatment groups (n=40/group) and will receive either: therapeutic massage or relaxation control treatment once a day for 3 consecutive days. Anxiety, state and trait, will be measured pre and post each treatment through a standardized tool and physiologic measures (heart rate \& blood pre(state and trait) and sleep efficiency will be determined through actigraphy and daily sleep logs.
Conditions
- Substance Withdrawal Syndrome
- Drug Withdrawal Symptoms
- Anxiety
Interventions
- PROCEDURE
-
Therapeutic Massage
Massage therapists with at least 5 years experience will perform the massages. On each of three consecutive days, participants (while fully clothed and in a seated position) will receive a 20-minute back, shoulder, neck and head massage. Subjects will be treated with conventional light pressure Swedish massage techniques which consisted of continuous systematic strokes including kneading and stretching to loosen and rehabilitate the soft tissues of the body and to provide general relaxation. The manual techniques include: effleurage , soothing petrissage , repetitive stroking, rocking , squeezing and mild joint mobilization. As is standard practice in massage therapy delivery, room lights will be dimmed and soft, soothing music played to enhance relaxation during therapy.
- PROCEDURE
-
Relaxation Control
On each of three consecutive evenings, subjects in this group will participate in a 20 minute relaxation session. This session will be delivered in the same location and with the same lighting and music as with the therapeutic massage group. Each participant will be asked to choose a comfortable position in a chair and a massage therapist will sit quietly in the room approximately 4 feet behind the participant.
Sponsors & Collaborators
-
Holistic Health Research Foundation of Canada
collaborator OTHER -
Dalhousie University
lead OTHER
Principal Investigators
-
Robert W Gilbert, PhD · Dalhousie University
-
Shaun Black, MSc · Capital District Health Authority, Addiction Prevention and Treatment Services
-
Kathleen Jacques, PhD, RMT · Canadian College of Massage and Hydrotherapy
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- DOUBLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 65 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2008-06-30
- Primary Completion
- 2009-01-31
- Completion
- 2009-01-31
Countries
- Canada
Study Locations
More Related Trials
-
Oxytocin Treatment of Alcohol Withdrawal
NCT01212185 ·Status: COMPLETED ·Phase: PHASE1
-
Bright Light Therapy During Residential Alcohol Withdrawal
NCT06878287 ·Status: RECRUITING ·Phase: NA
-
Outpatient Treatment of Alcohol Withdrawal Syndrome
NCT00136617 ·Status: COMPLETED ·Phase: PHASE3
-
Combining Non-Invasive Brain Stimulation With Cognitive Behavioral Intervention in Substance Use Disorder
NCT02570763 ·Status: WITHDRAWN ·Phase: NA
-
Outpatient Psychotherapeutic Treatment for Alcohol Dependent Individuals With Comorbid Psychiatric Disorders
NCT02141789 ·Status: COMPLETED ·Phase: NA
-
Combination of Naltrexone and Baclofen for Alcohol Dependence:A Pilot Study.
NCT00614328 ·Status: COMPLETED ·Phase: PHASE1
-
Oxytocin Treatment of Alcohol Dependence
NCT02251912 ·Status: COMPLETED ·Phase: PHASE2
-
Integrative Therapy in Alcoholism
NCT00159107 ·Status: COMPLETED ·Phase: PHASE4
-
The Effect of Prescription Medications in Marijuana Users
NCT00893074 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Blended Care for the Discontinuation of Benzodiazepine Use
NCT03937180 ·Status: COMPLETED ·Phase: NA
-
Study of Exploratory Plasmatic Markers of Alcohol Withdrawal
NCT05216705 ·Status: COMPLETED
-
Safety and Efficacy of a FAAH-Inhibitor to Treat Cannabis Withdrawal
NCT01618656 ·Status: COMPLETED ·Phase: PHASE2
-
Promoting Benzodiazepine Cessation Through an Electronically-delivered Patient Self-management Intervention
NCT04572750 ·Status: COMPLETED ·Phase: NA
-
Dexmedetomidine as Adjunctive Therapy for Alcohol Withdrawal
NCT00936377 ·Status: COMPLETED ·Phase: NA
-
Dronabinol Treatment for Marijuana Addiction
NCT00217971 ·Status: COMPLETED ·Phase: PHASE2
-
Effect of Baclofen on Marijuana Withdrawal and Relapse
NCT00373295 ·Status: COMPLETED ·Phase: PHASE2
-
How to Ease the Withdrawal of Tranquilizers Among Older Consumers?
NCT02281175 ·Status: COMPLETED ·Phase: NA
-
Development of an Anxiety Sensitivity-Based Intervention for Substance Use and Anxiety Comorbidity
NCT02667015 ·Status: COMPLETED ·Phase: PHASE2
-
Oxytocin and Alcohol Withdrawal and Dependence
NCT02903251 ·Status: COMPLETED ·Phase: PHASE3
-
Computer-Delivered PFI for Anxiety Sensitivity/Alcohol Intervention for Hazardous Drinkers With Elevated Anxiety Sensitivity
NCT03917875 ·Status: COMPLETED ·Phase: NA
-
Treatment of Alcohol Withdrawal in Hospital Patients
NCT00249366 ·Status: COMPLETED ·Phase: PHASE4
-
Using Transcutaneous Auricular Vagus Nerve Stimulation to Treat Acute Alcohol Withdrawal
NCT04159909 ·Status: WITHDRAWN ·Phase: NA
-
Assessment of Energetic Resonance by Cutaneous Stimulation on Withdrawal Alcohol Symptoms.
NCT02146716 ·Status: COMPLETED ·Phase: NA
-
Hyperbaric Oxygen Therapy Compared to Cognitive Training in FASD
NCT04664790 ·Status: WITHDRAWN ·Phase: NA
-
Safety & Efficacy of Baclofen for Alcohol Withdrawal in Chronic Liver Disease With Active Alcohol Consumption
NCT06840652 ·Status: ENROLLING_BY_INVITATION